<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4069411</article-id><article-id pub-id-type="publisher-id">cc13534</article-id><article-id pub-id-type="doi">10.1186/cc13534</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Clostridium difficile infection in ICU patients</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Belesiotou</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Routsi</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Nepka</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Magira</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Kaltsas</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Psaroudaki</surname><given-names>Z</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Kraniotaki</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Argyropoulou</surname><given-names>A</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Pittaras</surname><given-names>T</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Zakynthinos</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Evangelismos Hospital, Athens, Greece</aff><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>17</day><month>3</month><year>2014</year></pub-date><volume>18</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">34th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Publication of this supplement was supported by ISICEM.</named-content></supplement><fpage>P344</fpage><lpage>P344</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Belesiotou et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Belesiotou et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access"><license-p>This article is one of ten reviews selected from the <italic>Annual Update in Intensive Care and Emergency Medicine </italic>2014 and co-published as a series in <italic>Critical Care</italic>. Other articles in the series can be found online at <ext-link ext-link-type="uri" xlink:href="http://ccforum.com/series/annualupdate2014">http://ccforum.com/series/annualupdate2014</ext-link>. Further information about the <italic>Annual Update in Intensive Care and Emergency Medicine </italic>is available from <ext-link ext-link-type="uri" xlink:href="http://www.springer.com/series/8901">http://www.springer.com/series/8901</ext-link>.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/18/S1/P344"/><conference><conf-date>18-21 March 2014</conf-date><conf-name>34th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p><italic>Clostridium difficile </italic>infection is becoming more common worldwide. Critically ill patients are at particularly high risk for this disease due to multiple risk factors in this population. Accurate diagnosis is essential for patient management, infection control and epidemiology. There are a variety of methods to detect the presence of toxigenic <italic>C. difficile </italic>in stools [<xref ref-type="bibr" rid="B1">1</xref>],[<xref ref-type="bibr" rid="B2">2</xref>]. The aim of this study was to evaluate the incidence of <italic>C. difficile </italic>infection in our ICU. Laboratory results of <italic>C. difficile </italic>toxin detection performed by the methods available in our institution are presented.</p></sec><sec sec-type="methods"><title>Methods</title><p>During the last year, all stool specimens received in the microbiology department from patients hospitalized in the 30-bed, multidisciplinary ICU of a tertiary-care hospital were evaluated. Specimens were ordered by physicians in the presence of clinical features compatible with <italic>C. </italic>difficile-associated infection. Each specimen was subjected to diagnostic tests for <italic>C. difficile </italic>infection including toxin enzyme immunoassays for <italic>C. difficile </italic>toxins A and B detection (DUO Toxin A&#x00026;B; VEDA.LAB, France), and glutamate dehydrogenase (GDH) for cell wall antigen detection (C. DIFF Quik Chek Complete<sup>&#x000ae;</sup>; USA).</p></sec><sec sec-type="results"><title>Results</title><p>During the study period, 335 stool specimens were evaluated. Results obtained with the two-stage immunoassay tests are shown in Figure <xref ref-type="fig" rid="F1">1</xref>. All infected patients were treated with metronidazole or vancomycin. Following a course of therapy, 2% of the infected patients had recurrence or relapse. The crude mortality rate was 17%.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Illustration of the tests performed for detection of C. difficile</bold>.</p></caption><graphic xlink:href="cc13534-1"/></fig></sec><sec sec-type="conclusions"><title>Conclusion</title><p>GDH antigen was positive in 12% of the stool specimens received from ICU patients with suspected <italic>C. difficile </italic>-associated infections. The majority of these specimens (51.4%) produce both <italic>C. difficile </italic>toxins A and B, whereas toxin B is produced in 31.4% and toxin A in the remaining 17.2%.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="other"><name><surname>Bobo</surname><given-names>LB</given-names></name><etal/><source>Chest</source><year>2011</year><volume>140</volume><fpage>1643</fpage><pub-id pub-id-type="doi">10.1378/chest.11-0556</pub-id><pub-id pub-id-type="pmid">22147824</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="other"><name><surname>Cohen</surname><given-names>SH</given-names></name><etal/><source>Infect Control Clin Epidemiol</source><year>2010</year><volume>315</volume><fpage>431</fpage></mixed-citation></ref></ref-list></back></article>